Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000230583

Medchemexpress LLC 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine | 362665-56-3 | 99.7% | 5 MG
SDP

Catalog No. 5000230583
Encompass_Preferred

Pitolisant is a potent, selective nonimidazole inverse agonist of the histamine H3 receptor supplied as an analytical standard for research and analytical applications. It is provided as a high-purity liquid suitable for pharmacological studies and method development.

  • CAS number 362665-56-3
  • IUPAC name 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine
  • Molecular formula C17H26ClNO
  • Molecular weight 295.85 g/mol
  • Purity 99.7% (HPLC)
  • Appearance colorless to light yellow liquid
  • Available in small mg quantities and as a 10 mM solution in DMSO
  • Intended for research use and H3 receptor pharmacology studies

Catalog No. 50-002-30583 Supplier Medchemexpress LLC Supplier No. HY121995MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pitolisant is a potent, selective nonimidazole inverse agonist of the histamine H3 receptor supplied as an analytical standard for research and analytical applications. It is provided as a high-purity liquid suitable for pharmacological studies and method development.

  • CAS number 362665-56-3
  • IUPAC name 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine
  • Molecular formula C17H26ClNO
  • Molecular weight 295.85 g/mol
  • Purity 99.7% (HPLC)
  • Appearance colorless to light yellow liquid
  • Available in small mg quantities and as a 10 mM solution in DMSO
  • Intended for research use and H3 receptor pharmacology studies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.